Skip to main content
Premium Trial:

Request an Annual Quote

Univ. of Manchester Buys Cell Biosciences System

NEW YORK (GenomeWeb News) – Cell Biosciences has sold one of its protein analysis systems to The University of Manchester, the company said today.

The university will use the system in its Stem Cell and Leukemia Proteomics Laboratory to study how phosphoprotein signaling processes in hematopoietic stem calls are different during leukemia.

The platform is a nanofluidic immunoassay system designed to analyze extremely small biological samples, and it can measure cell signaling proteins reproducibly in numbers as small as 25 cells.

Financial terms of the agreement were not released.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.